Command Palette

Search for a command to run...

Clinical Trials · NCT00422058

The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes

CompletedPhase 2Liraglutide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Novo Nordisk A/S
Enrollment
564
Start date
Jan 2007
Locations
19 sites, 8 countries
Primary endpoint
Mean Change From Baseline in Body Weight at Week 20
View Liraglutide compound reference